-
Something wrong with this record ?
Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes
V. Bartáková, A. Pleskačová, K. Kuricová, L. Pácal, V. Dvořáková, J. Bělobrádková, M. Tomandlová, J. Tomandl, K. Kaňková,
Language English Country United States
Document type Clinical Trial, Journal Article
Grant support
NT13198
MZ0
CEP Register
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Adult MeSH
- Erythrocytes metabolism MeSH
- Diabetes, Gestational blood MeSH
- Humans MeSH
- Membrane Transport Proteins blood MeSH
- Follow-Up Studies MeSH
- Glycation End Products, Advanced blood MeSH
- Pregnancy MeSH
- Thiamine Pyrophosphate blood MeSH
- Transketolase blood MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
While the pathogenic role of dicarbonyl stress and accelerated formation of advanced glycation end products (AGEs) to glucose intolerance and to the development of diabetic complications is well established, little is known about these processes in gestational diabetes mellitus (GDM), a condition pathogenically quite similar to type 2 diabetes. The aims of the present study were (i) to determine plasma thiamine and erythrocyte thiamine diphosphate (TDP) and transketolase (TKT) activity in pregnant women with and without GDM, (ii) to assess relationships between thiamine metabolism parameters and selected clinical, biochemical and anthropometric characteristics and, finally, (iii) to analyse relationship between variability in the genes involved in the regulation of transmembrane thiamine transport (i.e. SLC19A2 and SLC19A3) and relevant parameters of thiamine metabolism. We found significantly lower plasma BMI adjusted thiamine in women with GDM (P = 0.002, Mann-Whitney) while levels of erythrocyte TDP (an active TKT cofactor) in mid-trimester were significantly higher in GDM compared to controls (P = 0.04, Mann-Whitney). However, mid-gestational TKT activity - reflecting pentose phosphate pathway activity - did not differ between the two groups (P > 0.05, Mann-Whitney). Furthermore, we ascertained significant associations of postpartum TKT activity with SNPs SLC19A2 rs6656822 and SLC19A3 rs7567984 (P = 0.03 and P = 0.007, resp., Kruskal-Wallis). Our findings of increased thiamine delivery to the cells without concomitant increase of TKT activity in women with GDM therefore indicate possible pathogenic role of thiamine mishandling in GDM. Further studies are needed to determine its contribution to maternal and/or neonatal morbidity.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017213
- 003
- CZ-PrNML
- 005
- 20191002081521.0
- 007
- ta
- 008
- 180515s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10719-016-9688-9 $2 doi
- 035 __
- $a (PubMed)27287225
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bartáková, Vendula $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic. $7 xx0240193
- 245 10
- $a Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes / $c V. Bartáková, A. Pleskačová, K. Kuricová, L. Pácal, V. Dvořáková, J. Bělobrádková, M. Tomandlová, J. Tomandl, K. Kaňková,
- 520 9_
- $a While the pathogenic role of dicarbonyl stress and accelerated formation of advanced glycation end products (AGEs) to glucose intolerance and to the development of diabetic complications is well established, little is known about these processes in gestational diabetes mellitus (GDM), a condition pathogenically quite similar to type 2 diabetes. The aims of the present study were (i) to determine plasma thiamine and erythrocyte thiamine diphosphate (TDP) and transketolase (TKT) activity in pregnant women with and without GDM, (ii) to assess relationships between thiamine metabolism parameters and selected clinical, biochemical and anthropometric characteristics and, finally, (iii) to analyse relationship between variability in the genes involved in the regulation of transmembrane thiamine transport (i.e. SLC19A2 and SLC19A3) and relevant parameters of thiamine metabolism. We found significantly lower plasma BMI adjusted thiamine in women with GDM (P = 0.002, Mann-Whitney) while levels of erythrocyte TDP (an active TKT cofactor) in mid-trimester were significantly higher in GDM compared to controls (P = 0.04, Mann-Whitney). However, mid-gestational TKT activity - reflecting pentose phosphate pathway activity - did not differ between the two groups (P > 0.05, Mann-Whitney). Furthermore, we ascertained significant associations of postpartum TKT activity with SNPs SLC19A2 rs6656822 and SLC19A3 rs7567984 (P = 0.03 and P = 0.007, resp., Kruskal-Wallis). Our findings of increased thiamine delivery to the cells without concomitant increase of TKT activity in women with GDM therefore indicate possible pathogenic role of thiamine mishandling in GDM. Further studies are needed to determine its contribution to maternal and/or neonatal morbidity.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a gestační diabetes $x krev $7 D016640
- 650 _2
- $a erytrocyty $x metabolismus $7 D004912
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a produkty pokročilé glykace $x krev $7 D017127
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a membránové transportní proteiny $x krev $7 D026901
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a thiaminpyrofosfát $x krev $7 D013835
- 650 _2
- $a transketolasa $x krev $7 D014174
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pleskačová, Anna $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic. Department of Biochemistry, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00, Brno, Czech Republic.
- 700 1_
- $a Chalásová, Katarína, $d 1986- $7 mub2017949800 $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic.
- 700 1_
- $a Pácal, Lukáš $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic. $7 xx0084072
- 700 1_
- $a Dvořáková, Veronika $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic.
- 700 1_
- $a Bělobrádková, Jana $u Diabetes Centre, Department of Internal Medicine - Gastroenterology, University Hospital Brno, Jihlavská 20, 625 00, Brno, Czech Republic. $7 mzk2007382258
- 700 1_
- $a Tomandlová, Marie $u Department of Biochemistry, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00, Brno, Czech Republic. $7 xx0230817
- 700 1_
- $a Tomandl, Josef, $u Department of Biochemistry, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00, Brno, Czech Republic. $d 1964- $7 mzk2003175507
- 700 1_
- $a Kaňková, Kateřina, $u Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, UKB Kamenice 5/A18, 625 00, Brno, Czech Republic. kankov@med.muni.cz. $d 1971- $7 mzk2003190820
- 773 0_
- $w MED00006846 $t Glycoconjugate journal $x 1573-4986 $g Roč. 33, č. 4 (2016), s. 591-598
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27287225 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20191002081929 $b ABA008
- 999 __
- $a ok $b bmc $g 1300837 $s 1014053
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 33 $c 4 $d 591-598 $e 20160610 $i 1573-4986 $m Glycoconjugate journal $n Glycoconj J $x MED00006846
- GRA __
- $a NT13198 $p MZ0
- LZP __
- $a Pubmed-20180515